Cargando…

Circulating microparticles: square the circle

BACKGROUND: The present review summarizes current knowledge about microparticles (MPs) and provides a systematic overview of last 20 years of research on circulating MPs, with particular focus on their clinical relevance. RESULTS: MPs are a heterogeneous population of cell-derived vesicles, with siz...

Descripción completa

Detalles Bibliográficos
Autores principales: Barteneva, Natasha S, Fasler-Kan, Elizaveta, Bernimoulin, Michael, Stern, Joel NH, Ponomarev, Eugeny D, Duckett, Larry, Vorobjev, Ivan A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651414/
https://www.ncbi.nlm.nih.gov/pubmed/23607880
http://dx.doi.org/10.1186/1471-2121-14-23
_version_ 1782269224972976128
author Barteneva, Natasha S
Fasler-Kan, Elizaveta
Bernimoulin, Michael
Stern, Joel NH
Ponomarev, Eugeny D
Duckett, Larry
Vorobjev, Ivan A
author_facet Barteneva, Natasha S
Fasler-Kan, Elizaveta
Bernimoulin, Michael
Stern, Joel NH
Ponomarev, Eugeny D
Duckett, Larry
Vorobjev, Ivan A
author_sort Barteneva, Natasha S
collection PubMed
description BACKGROUND: The present review summarizes current knowledge about microparticles (MPs) and provides a systematic overview of last 20 years of research on circulating MPs, with particular focus on their clinical relevance. RESULTS: MPs are a heterogeneous population of cell-derived vesicles, with sizes ranging between 50 and 1000 nm. MPs are capable of transferring peptides, proteins, lipid components, microRNA, mRNA, and DNA from one cell to another without direct cell-to-cell contact. Growing evidence suggests that MPs present in peripheral blood and body fluids contribute to the development and progression of cancer, and are of pathophysiological relevance for autoimmune, inflammatory, infectious, cardiovascular, hematological, and other diseases. MPs have large diagnostic potential as biomarkers; however, due to current technological limitations in purification of MPs and an absence of standardized methods of MP detection, challenges remain in validating the potential of MPs as a non-invasive and early diagnostic platform. CONCLUSIONS: Improvements in the effective deciphering of MP molecular signatures will be critical not only for diagnostics, but also for the evaluation of treatment regimens and predicting disease outcomes.
format Online
Article
Text
id pubmed-3651414
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36514142013-05-11 Circulating microparticles: square the circle Barteneva, Natasha S Fasler-Kan, Elizaveta Bernimoulin, Michael Stern, Joel NH Ponomarev, Eugeny D Duckett, Larry Vorobjev, Ivan A BMC Cell Biol Review BACKGROUND: The present review summarizes current knowledge about microparticles (MPs) and provides a systematic overview of last 20 years of research on circulating MPs, with particular focus on their clinical relevance. RESULTS: MPs are a heterogeneous population of cell-derived vesicles, with sizes ranging between 50 and 1000 nm. MPs are capable of transferring peptides, proteins, lipid components, microRNA, mRNA, and DNA from one cell to another without direct cell-to-cell contact. Growing evidence suggests that MPs present in peripheral blood and body fluids contribute to the development and progression of cancer, and are of pathophysiological relevance for autoimmune, inflammatory, infectious, cardiovascular, hematological, and other diseases. MPs have large diagnostic potential as biomarkers; however, due to current technological limitations in purification of MPs and an absence of standardized methods of MP detection, challenges remain in validating the potential of MPs as a non-invasive and early diagnostic platform. CONCLUSIONS: Improvements in the effective deciphering of MP molecular signatures will be critical not only for diagnostics, but also for the evaluation of treatment regimens and predicting disease outcomes. BioMed Central 2013-04-22 /pmc/articles/PMC3651414/ /pubmed/23607880 http://dx.doi.org/10.1186/1471-2121-14-23 Text en Copyright © 2013 Barteneva et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Barteneva, Natasha S
Fasler-Kan, Elizaveta
Bernimoulin, Michael
Stern, Joel NH
Ponomarev, Eugeny D
Duckett, Larry
Vorobjev, Ivan A
Circulating microparticles: square the circle
title Circulating microparticles: square the circle
title_full Circulating microparticles: square the circle
title_fullStr Circulating microparticles: square the circle
title_full_unstemmed Circulating microparticles: square the circle
title_short Circulating microparticles: square the circle
title_sort circulating microparticles: square the circle
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651414/
https://www.ncbi.nlm.nih.gov/pubmed/23607880
http://dx.doi.org/10.1186/1471-2121-14-23
work_keys_str_mv AT bartenevanatashas circulatingmicroparticlessquarethecircle
AT faslerkanelizaveta circulatingmicroparticlessquarethecircle
AT bernimoulinmichael circulatingmicroparticlessquarethecircle
AT sternjoelnh circulatingmicroparticlessquarethecircle
AT ponomareveugenyd circulatingmicroparticlessquarethecircle
AT duckettlarry circulatingmicroparticlessquarethecircle
AT vorobjevivana circulatingmicroparticlessquarethecircle